OR WAIT null SECS
Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.
This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.
Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.
May 02, 2014
New formulations and expanded vaccine production are encouraged.
May 01, 2014
Gallus BioPharmaceuticals enters a cell line optimization and manufacturing agreement with Omni Bio Pharmaceutical.
April 30, 2014
TAP Biosystems announced that Gallus BioPharmaceuticals is using its ambr15 micro bioreactor system to optimize process development and clone selection of novel antibody therapeutics and biosimilars.
April 15, 2014
Experts share insights on how product appearance such as size, shape, color, and imprint can make a difference in reducing medication errors.
Lifecycle management opportunities are impacting the development of controlled-release technologies for solid-dosage drugs.
Doug Hausner, Engineering Research Center for Structured Organic Particulate Systems, Rutgers University discusses continuous manufacturing for solid-dosage drug production.
The author discusses various aspects of the hot-melt extrusion process and outlines a practical approach to scale-up.
The authors describe how modular systems can be applied to continuous solid-dosage and nutraceutical manufacturing.
Charlie Martin, Leistritz Extrusion, describes hot-melt extrusion manufacturing processes and advances.
The author examines the effect of compaction force, gap width, and sieve setup on granule size.